Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Amring Pharmaceuticals is a specialty pharmaceutical company that identifies, develops, and commercializes high-value generic and niche brand-name products for the U.S. market. Founded in 2014 and headquartered in Berwyn, Pennsylvania, the company operates as the North American subsidiary of Nordic Pharma. Amring's portfolio spans several therapeutic categories, including ophthalmology, urology, endocrinology, and hematology, with a focus on complex formulations and delivery systems. The company emphasizes strategic partnerships with global manufacturers to ensure a consistent supply of essential medications. Amring is committed to providing cost-effective healthcare solutions while maintaining high standards of quality and regulatory compliance.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Amring Pharms.